EXTEDO Appoints Maximilian Munte as Managing Director

OTTOBRUNN, GERMANY — (Marketwire) — 02/04/13 — , a key Regulatory Information Management solutions provider for life sciences firms, today announced Maximilian Munte will join the company as Managing Director. Maximilian Munte will share the global management responsibilities with Martin Schmid, Managing Director of the EXTEDO group.Maximilian Munte has a well-rounded background as a leader and executive with over 14 years of experience in the life sciences and high technology industries. He

Chairman of GAMP Europe to Speak at German Life Sciences Compliance Management Seminars Hosted by QUMAS

Chairman of GAMP Europe to Speak at German Life Sciences Compliance Management Seminars Hosted by QUMAS

CORK, IRELAND — (Marketwire) — 03/08/12 — today announced that Chris Reid, Chairman of GAMP Europe, is to speak at two complimentary half-day Life Sciences seminars in Germany, focusing on Quality and Compliance Management trends. The first seminar will be held on Tuesday, March 20, 2012 in Frankfurt. The second seminar will be held on Wednesday, March 21, 2012 in Dusseldorf. Each seminar will cover the following topics:How to Implement an integrated (QMS) and leverage GAMP guidance to inc

Samsung Biologics Selects QUMAS Platform to Manage Compliance Across the Organization

Samsung Biologics Selects QUMAS Platform to Manage Compliance Across the Organization

CORK, IRELAND — (Marketwire) — 12/20/11 — announced today that it has been selected by to provide an integrated regulatory compliance platform. Samsung Biologics, which forms part of the Samsung Group, was established in February 2011 and aims to be a leader in the biopharmaceutical manufacturing industry, offering world-class mammalian cell-based cGMP contract manufacturing services.Samsung Biologics has started construction of a new manufacturing facility near Seoul and it is anticipat